Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M923Revenue $M45.9Net Margin (%)-47.2Z-Score13.9
Enterprise Value $M744EPS $-0.4Operating Margin %-49.6F-Score4
P/E(ttm))0Cash Flow Per Share $-0.6Pre-tax Margin (%)-48.6Higher ROA y-yY
Price/Book4.510-y EBITDA Growth Rate %-2.7Quick Ratio9.1Cash flow > EarningsY
Price/Sales19.65-y EBITDA Growth Rate %-4.7Current Ratio9.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-9.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-11.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M69.2ROI % (ttm)-33.3Gross Margin Increase y-yN

Gurus Latest Trades with SGMO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SGMOJoel Greenblatt 2014-12-31 Buy $9.85 - $16.53
($12.15)
$ 13.349%New holding17,441
SGMOJean-Marie Eveillard 2014-06-30 Add0.01%$11.71 - $17.95
($14.37)
$ 13.34-8%Add 34.10%536,380
SGMOJean-Marie Eveillard 2014-03-31 Reduce-0.02%$13.25 - $23.86
($19.12)
$ 13.34-43%Reduce -52.81%400,000
SGMOJean-Marie Eveillard 2013-09-30 Add0.01%$7.92 - $11.28
($9.95)
$ 13.3425%Add 99.73%847,550
SGMOJean-Marie Eveillard 2013-06-30 Add$7.31 - $10.65
($8.72)
$ 13.3435%Add 41.45%424,350
SGMOJean-Marie Eveillard 2013-03-31 Buy 0.01%$6.01 - $10.8
($8.89)
$ 13.3433%New holding300,000
SGMOJean-Marie Eveillard 2010-03-31 Sold Out $4.76 - $6.63
($5.63)
$ 13.3458%Sold Out0
SGMOJean-Marie Eveillard 2009-12-31 Buy $5.04 - $8.09
($5.87)
$ 13.3456%New holding470
SGMOJean-Marie Eveillard 2009-09-30 Sold Out -0.01%$4.26 - $9.03
($6.32)
$ 13.3453%Sold Out0
SGMOJean-Marie Eveillard 2009-06-30 Buy 0.01%$3.51 - $4.98
($4.2)
$ 13.3469%New holding260,600
SGMOJean-Marie Eveillard 2009-03-31 Sold Out -0.01%$2.99 - $5.05
($4.1)
$ 13.3469%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SGMO is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SGMO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LANPHIER EDWARD O IIPresident & CEO 2015-04-15Sell25,000$15.33-4.11view
Wolff Henry WardExec VP & CFO 2015-04-10Sell12,000$15.31-3.98view
RINGO WILLIAM RDirector 2015-04-06Sell2,200$14.95-1.67view
ANDO DALE GVP, Therapeutic Dev. & CMO 2015-04-06Sell15,000$14.94-1.61view
Gregory Philip DSVP of Research & CSO 2015-04-01Sell15,000$15.15-2.97view
Wolff Henry WardExec VP & CFO 2015-03-19Sell10,000$18-18.33view
LANPHIER EDWARD O IIPresident & CEO 2015-03-16Sell25,000$17.29-14.98view
Wolff Henry WardExec VP & CFO 2015-03-10Sell12,000$16.68-11.87view
ANDO DALE GVP, Therapeutic Dev. & CMO 2015-03-05Sell15,000$18.29-19.63view
Mento Steven JDirector 2015-03-05Sell6,501$18.3-19.67view

Press Releases about SGMO :

    Quarterly/Annual Reports about SGMO:

    News about SGMO:

    Articles On GuruFocus.com
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Nov 03 2010 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Aug 05 2010 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) May 05 2010 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Nov 06 2009 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) Aug 03 2009 
    Sangamo BioSciences Inc. Reports Operating Results (10-Q) May 05 2009 
    Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results Feb 04 2009 

    More From Other Websites
    First experiment 'editing' human embryos ignites ethical furor Apr 23 2015
    First experiment 'editing' human embryos ignites ethical furor Apr 23 2015
    First experiment 'editing' human embryos ignites ethical furor Apr 23 2015
    Street Talk: SKX, FFIV, STJ, TCBI & SGMO Apr 23 2015
    Sangamo BioSciences Inc Earnings Call scheduled for 5:00 pm ET today Apr 22 2015
    Sangamo reports 1Q loss Apr 22 2015
    Sangamo reports 1Q loss Apr 22 2015
    SANGAMO BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Apr 22 2015
    Sangamo BioSciences Reports First Quarter 2015 Financial Results Apr 22 2015
    Sangamo BioSciences Reports First Quarter 2015 Financial Results Apr 22 2015
    Q1 2015 Sangamo BioSciences Inc Earnings Release - After Market Close Apr 22 2015
    Sangamo BioSciences Announces First Quarter 2015 Conference Call and Webcast Apr 15 2015
    Sangamo BioSciences Announces First Quarter 2015 Conference Call and Webcast Apr 15 2015
    Sangamo BioSciences Announces Participation In The 3rd Annual Regen Med Investor Day Meeting In New... Mar 19 2015
    Sangamo BioSciences Announces Participation In The 3rd Annual Regen Med Investor Day Meeting In New... Mar 18 2015
    Sangamo BioSciences CEO To Present State Of The Industry Address At Alliance For Regenerative... Mar 09 2015
    Sangamo BioSciences CEO To Present State Of The Industry Address At Alliance For Regenerative... Mar 09 2015
    SANGAMO BIOSCIENCES INC Financials Mar 04 2015
    Sangamo Biosciences (SGMO) is in Overbought Territory: What's Next? - Tale of the Tape Mar 03 2015
    10-K for Sangamo BioSciences, Inc. Feb 27 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK